LY-339434
LY-339434 is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known as a selective antagonist of the 5-HT2A receptor, a subtype of the serotonin receptor. This compound has been of interest in the field of neuropsychopharmacology due to its potential implications in the treatment of various psychiatric disorders.
Chemical Structure and Properties[edit | edit source]
LY-339434 is a synthetic compound with a complex chemical structure. It belongs to the class of phenylpiperazine derivatives, which are known for their activity on serotonin receptors. The molecular formula of LY-339434 is C20H25N3O2, and it has a molecular weight of approximately 339.44 g/mol.
Pharmacology[edit | edit source]
LY-339434 acts as a selective antagonist at the 5-HT2A receptor, which is one of the several subtypes of serotonin receptors found in the central nervous system. The 5-HT2A receptor is implicated in various neurological and psychiatric processes, including mood regulation, perception, and cognition.
Mechanism of Action[edit | edit source]
As an antagonist, LY-339434 binds to the 5-HT2A receptor and inhibits the action of serotonin (5-HT) at this site. This blockade can modulate the downstream signaling pathways that are typically activated by serotonin, potentially leading to alterations in mood, perception, and other cognitive functions.
Potential Therapeutic Applications[edit | edit source]
Research into LY-339434 has suggested potential applications in the treatment of disorders such as schizophrenia, depression, and anxiety disorders. By modulating the activity of the 5-HT2A receptor, LY-339434 may help alleviate symptoms associated with these conditions.
Research and Development[edit | edit source]
The development of LY-339434 has primarily been in the preclinical stage, with studies focusing on its pharmacokinetics, pharmacodynamics, and safety profile. Animal studies have been conducted to assess its efficacy and potential side effects.
Safety and Side Effects[edit | edit source]
As with many investigational drugs, the safety profile of LY-339434 is still under investigation. Common side effects observed in preclinical studies include alterations in behavior and physiological responses, which are typical of compounds affecting the central nervous system.
Also see[edit | edit source]
 | This article about a biochemical receptor is a stub. You can help WikiMD by expanding it. |
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
